| Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials C Axfors, AM Schmitt, P Janiaud, J Van’t Hooft, S Abd-Elsalam, EF Abdo, ... Nature communications 12 (1), 2349, 2021 | 336 | 2021 |
| Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient D Zhou, HME Duyvesteyn, CP Chen, CG Huang, TH Chen, SR Shih, ... Nature structural & molecular biology 27 (10), 950-958, 2020 | 286 | 2020 |
| A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to … CP Chen, YC Lin, TC Chen, TY Tseng, HL Wong, CY Kuo, WP Lin, ... PloS one 15 (12), e0242763, 2020 | 98 | 2020 |
| Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan CY Cheng, YL Lee, CP Chen, YC Lin, CE Liu, CH Liao, SH Cheng Journal of Microbiology, Immunology and Infection 53 (3), 488-492, 2020 | 80 | 2020 |
| Breadth and function of antibody response to acute SARS-CoV-2 infection in humans KYA Huang, TK Tan, TH Chen, CG Huang, R Harvey, S Hussain, ... Plos pathogens 17 (2), e1009352, 2021 | 70 | 2021 |
| Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination WH Sheng, SY Chang, PH Lin, MJ Hsieh, HH Chang, CY Cheng, ... Journal of the Formosan Medical Association 121 (4), 766-777, 2022 | 25 | 2022 |
| A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response YC Lin, CY Cheng, CP Chen, SH Cheng, SY Chang, PR Hsueh International Journal of Infectious Diseases 96, 464-466, 2020 | 22 | 2020 |
| Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan SF Huang, YC Huang, FY Chang, JC Lin, CH Chiu, CW Chen, FD Wang, ... Biomedical journal 43 (4), 314-317, 2020 | 21 | 2020 |
| Early seroreversion after 2 doses of hepatitis A vaccination in human immunodeficiency virus–positive patients: incidence and associated factors SH Huang, CH Huang, NC Wang, TC Chen, YT Lee, SP Lin, TY Lin, ... Hepatology 70 (2), 465-475, 2019 | 19 | 2019 |
| An immunobridging study to evaluate the neutralizing antibody titer in adults immunized with two doses of either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901 JA Estrada, CY Cheng, SY Ku, HC Hu, HW Yeh, YC Lin, CP Chen, ... Vaccines 10 (5), 655, 2022 | 15 | 2022 |
| Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison … CP Chen, CY Cheng, H Zou, CH Cheng, SH Cheng, CK Chen, CH Chen, ... Journal of Microbiology, Immunology and Infection 52 (4), 556-562, 2019 | 14 | 2019 |
| The association of molecular typing, vancomycin MIC, and clinical outcome for patients with methicillin-resistant Staphylococcus aureus infections CP Chen, MF Liu, CF Lin, SP Lin, ZY Shi Journal of microbiology, immunology and infection 50 (5), 619-626, 2017 | 10 | 2017 |
| Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan YC Lin, YL Lee, CY Cheng, WP Tseng, JL Wu, CH Lin, MY Chung, ... Journal of Microbiology, Immunology and Infection 54 (5), 816-829, 2021 | 9 | 2021 |
| Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials C Axfors, AM Schmitt, P Janiaud, J van’t Hooft, S Abd-Elsalam, EF Abdo, ... Nature communications 15 (1), 1075, 2024 | 8 | 2024 |
| Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2 KYA Huang, D Zhou, TK Tan, C Chen, HME Duyvesteyn, Y Zhao, ... Theranostics 12 (1), 1, 2022 | 8 | 2022 |
| Clinical validation of an automated reverse transcription-insulated isothermal PCR assay for the detection of severe acute respiratory syndrome coronavirus 2 PL Chang, CY Lin, CP Chen, YC Lin, HC Hu, SH Cheng, CY Cheng Journal of Microbiology, Immunology and Infection 54 (3), 522-526, 2021 | 8 | 2021 |
| Incidence and risk factors of reinfection with HCV after treatment in people living with HIV CY Cheng, SY Ku, YC Lin, CP Chen, SH Cheng, IF Lin Viruses 14 (2), 439, 2022 | 7 | 2022 |
| Nontyphoidal salmonella urinary tract infection in a case of hyperparathyroidism and nephrocalcinosis CP Chen, ZY Shi, CH Chen, WM Chen, YH Lin, CA Tsai, SP Lin, ... The West Indian Medical Journal 63 (1), 94, 2014 | 5 | 2014 |
| Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun 12 (1): 2349 C Axfors, AM Schmitt, P Janiaud, J Van’t Hooft, S Abd-Elsalam, EF Abdo, ... | 3 | 2021 |
| Predicting Emotional Valence of People Living with the Human Immunodeficiency Virus Using Daily Voice Clips: A Preliminary Study RF Lin, SH Cheng, YP Liu, CP Chen, YJ Wang, SY Chang Healthcare 9 (9), 1148, 2021 | 1 | 2021 |
